Helport AI Advances Transition to Autonomous AI Labor in Southeast Asian Fintech Market argenx announces full exercise of underwriters’ option to purchase additional ADSs
Regulated information — Inside information February 4, 2021 Breda, the Netherlands — argenx SE (Euronext &…
Roche reports solid results in 2020
Basel, 4 February 2021 Group sales increase 1%1 at constant exchange rates (CER); 5% decline…
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards…
Idorsia announces financial results for 2020 – a successful year marked by outstanding clinical data
Allschwil, Switzerland – February 4, 2021 Idorsia Ltd (SIX: IDIA) today announced its financial results…
Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD) today…
Sana Announces Upsized Pricing of Initial Public Offering
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company…
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Switzerland to purchase six million doses of the Novavax vaccine candidate, NVX-CoV2373 GAITHERSBURG, Md., Feb….
Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc., a clinical-stage…
Landos Biopharma Announces Pricing of Initial Public Offering
BLACKSBURG, Va., Feb. 03, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, a clinical-stage biopharmaceutical company focused…
Iterum Therapeutics plc Announces $10 Million Bought Deal Public Offering of Ordinary Shares
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Psyence Group Presenting at Canaccord Genuity Conference “New Paradigms & Treatment Approaches in Mental Health”
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger…
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Medexus Announces Upsize to Previously Announced Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…